About
Priya is currently working on her thesis titled “Design and Synthesis of 3,7-Dihydro-1H-Purine-2,6-Diones as Inhibitors of DPP-4 for the Management of Type 2 Diabetes Mellitus” for M. Pharm, in the department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga. She has prior experience in Computer-aided drug designing, synthesizing, characterizing, and evaluating novel compounds as anti-hyperglycemic agent targeting DPP-4. She has worked with in silico techniques such as molecular docking and simulation during her project. She is also familiar with animal handling, dosing, evaluation of behavioral parameters, and histological staining. She is a highly motivated individual who is willing to learn and acquire new skills.
Employment
Employment history is unavailable.
Education
-
Indo Soviet Friendship College of Pharmacy Masters of Pharmaceutical Chemistry2021 - 2023
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Exploring the pharmacological versatility of triazolopyrazine: A multi-target scaffold for drug development Save
- Unveiling the medicinal diversity of benzoic acid containing molecules: Insights on druggable targets for type 2 diabetes mellitus Save
- Designing of xanthine-based DPP-4 inhibitors: a structure-guided alignment dependent Multifacet 3D-QSAR modeling, and molecular dynamics simulation study Save
- Pyrimidine‐2,4‐dione‐Based DPP‐4 Inhibitors: A Structure‐Guided Multifaced 3D‐QSAR and Molecular Dynamics Studies Save
- Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agents Save
- Design and synthesis of novel 3,7-dihydro-1H-purine-2,6-diones as DPP-4 inhibitors: An in silico, in vitro and in vivo approach Save
- Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations Save
- A comprehension on structure guided alignment dependent 3D-QSAR modelling, and molecular dynamics simulation on 2,4-thiazolidinediones as aldose reductase inhibitors for the management of diabetic complications Save
- A comprehensive update on phytochemistry, analytical aspects, medicinal attributes, specifications and stability of stigmasterol Save
- A comprehension on synthetic strategies of Aurora kinase A and B inhibitors Save